This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vigne, J.-L. Articles by Taylor, R. N. Search for Related Content PubMed PubMed Citation Articles by Vigne, J.-L. Articles by Taylor, R. N.

Elevated Nonesterified Fatty Acid Concentrations in Severe Preeclampsia Shift the Isoelectric Characteristics of Plasma Albumin¹

Departments of Obstetrics, Gynecology, and Reproductive Sciences (J.L.V., S.J.F., R.N.T.), Stomatology (S.J.F.), and the Mass Spectrometry Facility (W.P.J., S.J.F.), University of California, San Francisco, California 94143; Geron Corp., Inc. (J.T.M.), Menlo Park, California 94025; and Arbogast Pharmaceuticals, Inc. (B.W.A.), Johnson City, Tennessee 37601

Address all correspondence and requests for reprints to: Robert N. Taylor, M.D., Ph.D., Reproductive Endocrinology Center, HSE 1679, University of California School of Medicine, San Francisco, California 94143-0556.

We previously hypothesized that the endothelial cell dysfunction observed in women with preeclampsia might be caused by an imbalance between circulating very low density lipoproteins and a cytoprotective pI 5.6 isoform of albumin, referred to as toxicity preventing albumin (TxPA). An accurate simplified method was developed to quantify TxPA in small volumes of pregnancy plasma by gel electrofocusing. This assay revealed that circulating TxPA concentrations in women with severe preeclampsia were significantly reduced compared to those in normal pregnant women and women with benign transient hypertension of pregnancy. Nonesterified fatty acids (NEFA) and triglycerides were elevated in plasma from women with severe preeclampsia compared to those in plasma from the two control groups. The inverse correlation between TxPA and NEFA values led us to analyze the NEFA bound to plasma albumin. Gas chromatography and mass spectrometry demonstrated no qualitative differences in the specific fatty acids bound to plasma albumin in severe preeclamptic and normal pregnant women. However, the quantity of NEFA bound to albumin was greater in preeclampsia plasma (2.5 mol NEFA/mol albumin) compared to that in normal pregnancy plasma (0.8 mol NEFA/mol albumin), accounting for the acidic pI shift observed in albumin from the former patients. Functional assays demonstrated that human very low density lipoprotein particles were toxic to human umbilical vein endothelial cells in vitro, but this toxicity was prevented by the addition of TxPA albumin to the culture medium.

This article has been cited by other articles:

				A. Tokumura, T. Kume, S. Taira, K. Yasuda, and H. Kanzaki Altered activity of lysophospholipase D, which produces bioactive lysophosphatidic acid and choline, in serum from women with pathological pregnancy Mol. Hum. Reprod., May 1, 2009; 15(5): 301 - 310. [Abstract] [Full Text] [PDF]

				L. L. Waite, R. E. Louie, and R. N. Taylor Circulating Activators of Peroxisome Proliferator-Activated Receptors Are Reduced in Preeclamptic Pregnancy J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 620 - 626. [Abstract] [Full Text] [PDF]

				R. E. Gandley, V. A. Tyurin, W. Huang, A. Arroyo, A. Daftary, G. Harger, J. Jiang, B. Pitt, R. N. Taylor, C. A. Hubel, et al. S-Nitrosoalbumin-Mediated Relaxation Is Enhanced by Ascorbate and Copper: Effects in Pregnancy and Preeclampsia Plasma Hypertension, January 1, 2005; 45(1): 21 - 27. [Abstract] [Full Text] [PDF]

				E. C. Person, L. L. Waite, R. N. Taylor, and T. S. Scanlan Albumin Regulates Induction of Peroxisome Proliferator-Activated Receptor-{{gamma}} (PPAR{{gamma}}) by 15-Deoxy-{{Delta}}12-14-Prostaglandin J2 in Vitro and May Be an Important Regulator of PPAR{{gamma}} Function in Vivo Endocrinology, February 1, 2001; 142(2): 551 - 556. [Abstract] [Full Text] [PDF]